Tibotec gets Incivo approved in Europe
This article was originally published in Scrip
Executive Summary
Tibotec Virco-Virology, a Janssen Pharmaceutical (J&J) subsidiary, will launch Incivo (telaprevir), its treatment for hepatitis C virus in Germany within the next week or so, following approval from the European Commission on 20 September 2011.